Global Cell and Gene Therapy Isolator Market Growth 2022-2028

Global Cell and Gene Therapy Isolator Market Growth 2022-2028

Product Code:423784

Published Date: Sep 27,2022

Pages: 114

Region: Global

Category: Medical Devices & Consumables

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US

The cell and gene therapy isolator integrates cell culture-related functional components such as centrifuges and CO2 incubators, and completes cell culture-related operations in a closed and sterile environment to meet GMP production requirements for cell products.

The global market for Cell and Gene Therapy Isolator is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Cell and Gene Therapy Isolator market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Cell and Gene Therapy Isolator market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Cell and Gene Therapy Isolator market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Cell and Gene Therapy Isolator market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Cell and Gene Therapy Isolator players cover Skan Holding, Netsteril, Comecer, Esco Pharma and Extract Technology, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global Cell and Gene Therapy Isolator market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Cell and Gene Therapy Isolator market, with both quantitative and qualitative data, to help readers understand how the Cell and Gene Therapy Isolator market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Units.

Market Segmentation:
The study segments the Cell and Gene Therapy Isolator market and forecasts the market size by Type (Mobile and Floor-standing,), by Application (Medicine, Laboratory and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
    Mobile
    Floor-standing

Segmentation by application
    Medicine
    Laboratory
    Others

Segmentation by region
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

Major companies covered
    Skan Holding
    Netsteril
    Comecer
    Esco Pharma
    Extract Technology
    Tema Sinergie
    Optima Pharma
    Bioquell
    BioSpherix
    Germfree
    Lonza
    Sony
    BioAir
    Ecolab
    ZheJiang Tailin Bioengineering
    JCE Biotechnology
    Euroclone

Chapter Introduction
Chapter 1: Scope of Cell and Gene Therapy Isolator, Research Methodology, etc.
Chapter 2: Executive Summary, global Cell and Gene Therapy Isolator market size (sales and revenue) and CAGR, Cell and Gene Therapy Isolator market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Cell and Gene Therapy Isolator sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Cell and Gene Therapy Isolator sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Cell and Gene Therapy Isolator market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Skan Holding, Netsteril, Comecer, Esco Pharma, Extract Technology, Tema Sinergie, Optima Pharma, Bioquell and BioSpherix, etc.
Chapter 14: Research Findings and Conclusion